Solventum (SOLV) Competitors $73.32 -0.47 (-0.63%) Closing price 03:59 PM EasternExtended Trading$72.16 -1.16 (-1.59%) As of 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SOLV vs. GEHC, PHG, ZBH, SNN, PEN, STVN, IRTC, BLCO, GKOS, and SLNOShould you be buying Solventum stock or one of its competitors? The main competitors of Solventum include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry. Solventum vs. Its Competitors GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Smith & Nephew SNATS Penumbra Stevanato Group iRhythm Technologies Bausch + Lomb Glaukos Soleno Therapeutics Solventum (NYSE:SOLV) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership. Which has more risk and volatility, SOLV or GEHC? Solventum has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500. Do analysts prefer SOLV or GEHC? Solventum currently has a consensus target price of $85.11, indicating a potential upside of 16.08%. GE HealthCare Technologies has a consensus target price of $88.40, indicating a potential upside of 15.65%. Given Solventum's higher probable upside, analysts plainly believe Solventum is more favorable than GE HealthCare Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.27GE HealthCare Technologies 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.91 Which has preferable earnings & valuation, SOLV or GEHC? GE HealthCare Technologies has higher revenue and earnings than Solventum. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolventum$8.25B1.54$478M$2.1633.95GE HealthCare Technologies$19.67B1.77$1.99B$4.8815.66 Does the media refer more to SOLV or GEHC? In the previous week, GE HealthCare Technologies had 5 more articles in the media than Solventum. MarketBeat recorded 27 mentions for GE HealthCare Technologies and 22 mentions for Solventum. GE HealthCare Technologies' average media sentiment score of 1.47 beat Solventum's score of 1.04 indicating that GE HealthCare Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 11 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive GE HealthCare Technologies 22 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is SOLV or GEHC more profitable? GE HealthCare Technologies has a net margin of 11.22% compared to Solventum's net margin of 4.52%. Solventum's return on equity of 29.93% beat GE HealthCare Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Solventum4.52% 29.93% 6.65% GE HealthCare Technologies 11.22%23.93%6.29% Do institutionals & insiders hold more shares of SOLV or GEHC? 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.1% of Solventum shares are held by insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryGE HealthCare Technologies beats Solventum on 13 of the 17 factors compared between the two stocks. Get Solventum News Delivered to You Automatically Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SOLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SOLV vs. The Competition Export to ExcelMetricSolventumMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$12.71B$7.58B$5.79B$21.48BDividend YieldN/A2.82%5.69%3.53%P/E Ratio33.9574.0174.5929.70Price / Sales1.5443.28453.5451.37Price / Cash7.1723.6037.0824.52Price / Book4.287.3512.154.58Net Income$478M$238.91M$3.28B$1.00B7 Day Performance0.86%2.63%0.99%0.66%1 Month Performance1.82%3.08%7.21%4.64%1 Year Performance6.81%20.54%63.07%15.96% Solventum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SOLVSolventum2.2837 of 5 stars$73.32-0.6%$85.11+16.1%+6.2%$12.71B$8.25B33.9522,000Positive NewsAnalyst DowngradeGEHCGE HealthCare Technologies4.3193 of 5 stars$78.16+3.2%$88.55+13.3%-10.6%$34.58B$19.97B16.0253,000Positive NewsPHGKoninklijke Philips3.3454 of 5 stars$27.88-0.2%N/A-6.0%$26.89B$17.86B146.7166,678Short Interest ↓ZBHZimmer Biomet4.7778 of 5 stars$104.74-0.9%$111.00+6.0%-0.9%$20.75B$7.68B25.4817,000Positive NewsInsider TradeSNNSmith & Nephew SNATS2.7769 of 5 stars$38.38+0.8%$36.00-6.2%+22.1%$16.81B$5.81B17.7717,349PENPenumbra4.6147 of 5 stars$285.15+1.3%$302.93+6.2%+36.8%$11.12B$1.19B75.844,500Positive NewsSTVNStevanato Group1.9419 of 5 stars€25.53+5.7%N/A+33.9%€7.73B€1.15B47.285,521Gap UpIRTCiRhythm Technologies1.3285 of 5 stars$187.07+3.3%$163.82-12.4%+141.9%$6.01B$591.84M-63.852,000News CoveragePositive NewsBLCOBausch + Lomb2.0783 of 5 stars$15.50+3.3%$15.56+0.3%-3.2%$5.49B$4.89B-19.8813,500News CoveragePositive NewsGKOSGlaukos4.7233 of 5 stars$91.83-2.2%$127.42+38.7%-30.3%$5.27B$383.48M-55.66780News CoveragePositive NewsAnalyst ForecastSLNOSoleno Therapeutics4.442 of 5 stars$72.30+3.6%$115.09+59.2%+16.8%$3.84BN/A-17.4630Trending NewsAnalyst UpgradeShort Interest ↑Analyst Revision Related Companies and Tools Related Companies GEHC Alternatives PHG Alternatives ZBH Alternatives SNN Alternatives PEN Alternatives STVN Alternatives IRTC Alternatives BLCO Alternatives GKOS Alternatives SLNO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SOLV) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SOLV Stock Alerts